REXAHN PHARMACEUTICALS, INC. (RXHN.OB) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 27 transactions totaling $92.1K, demonstrating a bullish sentiment with $92.1K in net insider flow. The most recent transaction on May 5, 2008 involved a purchase of 3,000 shares valued at $6.8K.
No significant insider buying has been recorded for RXHN.OB in the recent period.
No significant insider selling has been recorded for RXHN.OB in the recent period.
Based on recent SEC filings, insider sentiment for RXHN.OB is bullish with an Insider Alignment Score of 100/100 and a net flow of $92.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at REXAHN PHARMACEUTICALS, INC. (RXHN.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading RXHN.OB stock, having executed 27 transactions in the past 90 days. The most active insider is Charles Beever (Executive), who has made 9 transactions totaling $24.6K.
Get notified when executives and directors at RXHN.OB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 5, 2008 | Soo Cheong Kwang | Executive | Purchase | 3,000 | $2.25 | $6.8K | |
| Apr 24, 2008 | Michele Kang Y. | Executive | Purchase | 500 | $2.35 | $1.2K | |
| Apr 24, 2008 | Michele Kang Y. | Executive | Purchase | 1,500 | $2.35 | $3.5K | |
| Apr 23, 2008 | Michele Kang Y. | Executive | Purchase | 1,000 | $2.35 | $2.4K | |
| Apr 23, 2008 | Michele Kang Y. | Executive | Purchase | 1,000 | $2.35 | $2.4K | |
| Apr 23, 2008 | Michele Kang Y. | Executive | Purchase | 1,000 | $2.30 | $2.3K | |
| Apr 23, 2008 | Michele Kang Y. | Executive | Purchase | 2,500 | $2.30 | $5.8K | |
| Apr 23, 2008 | Michele Kang Y. | Executive | Purchase | 500 | $2.25 | $1.1K | |
| Apr 23, 2008 | Michele Kang Y. | Executive | Purchase | 1,000 | $2.35 | $2.4K | |
| Apr 23, 2008 | Michele Kang Y. | Executive | Purchase | 1,000 | $2.35 | $2.4K | |
| Apr 22, 2008 | Heum Jeong Tae | Executive | Purchase | 3,700 | $2.35 | $8.7K | |
| Apr 22, 2008 | Heum Jeong Tae | Executive | Purchase | 1,300 | $1.99 | $2.6K | |
| Apr 14, 2008 | Ho Ahn Chang | Executive | Purchase | 2,500 | $2.45 | $6.1K | |
| Apr 14, 2008 | Ho Ahn Chang | Executive | Purchase | 1,000 | $2.40 | $2.4K | |
| Apr 14, 2008 | Ho Ahn Chang | Executive | Purchase | 4,000 | $2.39 | $9.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 27 | $92.1K | 100.0% |
Insiders at REXAHN PHARMACEUTICALS, INC. are accumulating shares at an accelerated pace. With 6 insiders making 27 transactions totaling $92.1K in purchases versus $0 in sales, the net buying activity of $92.1K signals strong executive confidence. Charles Beever (Executive) leads the buying activity with $24.6K in transactions across all time.